EP4031122A4 - Formulations de comprimés effervescents comprenant de la dapagliflozine et de la metformine - Google Patents

Formulations de comprimés effervescents comprenant de la dapagliflozine et de la metformine Download PDF

Info

Publication number
EP4031122A4
EP4031122A4 EP20866500.0A EP20866500A EP4031122A4 EP 4031122 A4 EP4031122 A4 EP 4031122A4 EP 20866500 A EP20866500 A EP 20866500A EP 4031122 A4 EP4031122 A4 EP 4031122A4
Authority
EP
European Patent Office
Prior art keywords
dapagliflozin
metformin
effervescent tablet
tablet formulations
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20866500.0A
Other languages
German (de)
English (en)
Other versions
EP4031122A1 (fr
Inventor
Abdullah TASKIN
Yavuz Dedeoglu
Muge ULUSOY BOZYEL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanovel Ilac Sanayi ve Ticaret AS
Original Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS
Publication of EP4031122A1 publication Critical patent/EP4031122A1/fr
Publication of EP4031122A4 publication Critical patent/EP4031122A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
EP20866500.0A 2019-09-16 2020-08-05 Formulations de comprimés effervescents comprenant de la dapagliflozine et de la metformine Pending EP4031122A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2019/14043A TR201914043A1 (tr) 2019-09-16 2019-09-16 Dapagli̇flozi̇n ve metformi̇n i̇çeren efervesan tablet formülasyonlari
PCT/TR2020/050687 WO2021054912A1 (fr) 2019-09-16 2020-08-05 Formulations de comprimés effervescents comprenant de la dapagliflozine et de la metformine

Publications (2)

Publication Number Publication Date
EP4031122A1 EP4031122A1 (fr) 2022-07-27
EP4031122A4 true EP4031122A4 (fr) 2023-08-30

Family

ID=74883168

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20866500.0A Pending EP4031122A4 (fr) 2019-09-16 2020-08-05 Formulations de comprimés effervescents comprenant de la dapagliflozine et de la metformine

Country Status (3)

Country Link
EP (1) EP4031122A4 (fr)
TR (1) TR201914043A1 (fr)
WO (1) WO2021054912A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4079296A1 (fr) * 2021-04-21 2022-10-26 Sanovel Ilac Sanayi Ve Ticaret A.S. Formulation de comprimé bicouche comprenant de la dapagliflozine amorphe et de la metformine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150238421A1 (en) * 2009-11-13 2015-08-27 Astrazeneca Ab Bilayer Tablet Formulations
WO2017098481A1 (fr) * 2015-12-12 2017-06-15 Steerlife India Private Limited Compositions effervescentes de metformine et leurs procédés de préparation
WO2018185669A1 (fr) * 2017-04-07 2018-10-11 Zenvision Pharma Llp Compositions effervescentes comprenant de la saxagliptine ou un sel de celle-ci

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007038979A1 (fr) * 2005-09-22 2007-04-12 Swissco Development Ag Composition effervescente de metformine et comprimés et granules fabriqués à partir de cette composition
WO2013115743A1 (fr) * 2012-01-31 2013-08-08 Mahmut Bilgic Formulations de comprimés effervescents contenant la combinaison voglibose et metformine

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150238421A1 (en) * 2009-11-13 2015-08-27 Astrazeneca Ab Bilayer Tablet Formulations
WO2017098481A1 (fr) * 2015-12-12 2017-06-15 Steerlife India Private Limited Compositions effervescentes de metformine et leurs procédés de préparation
WO2018185669A1 (fr) * 2017-04-07 2018-10-11 Zenvision Pharma Llp Compositions effervescentes comprenant de la saxagliptine ou un sel de celle-ci

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2021054912A1 *

Also Published As

Publication number Publication date
EP4031122A1 (fr) 2022-07-27
WO2021054912A1 (fr) 2021-03-25
TR201914043A1 (tr) 2021-04-21

Similar Documents

Publication Publication Date Title
EP4051246A4 (fr) Formulations de comprimés bicouches comprenant de la dapagliflozine et de la metformine
IL284835A (en) Pharmaceutical combination containing TNO155 and ribociclib
EP4045480A4 (fr) Formulations pharmaceutiques
EP3706741A4 (fr) Composition pharmaceutique et utilisation associée
EP3938369A4 (fr) Inhibiteurs de tyk2 et leurs utilisations
EP3914357A4 (fr) Inhibiteurs de tyk2 et leurs utilisations
EP3904351A4 (fr) Inhibiteur de fak et combinaison de médicaments associée
EP3981769A4 (fr) Composé de pyrrolopyrimidine et son utilisation
EP4149470A4 (fr) Formulations pharmaceutiques et leurs utilisations
EP3851121A4 (fr) Composition pharmaceutique contenant un anticorps monoclonal anti-il-33 humain
EP3999183A4 (fr) Composé présentant une activité inhibitrice de kdm5 et utilisation pharmaceutique associée
EP3784672A4 (fr) Formulations de comprimés comprenant de la metformine et de la sitagliptine
EP3919498A4 (fr) Dérivé de pyrrolopyrimidine et son utilisation
EP3976014A4 (fr) Combinaison comprenant de l'alogliptine et de la metformine
EP4031122A4 (fr) Formulations de comprimés effervescents comprenant de la dapagliflozine et de la metformine
EP4112047A4 (fr) Comprimé oral complexe comprenant de la sitagliptine, de la dapagliflozine et de la metformine
EP3999056A4 (fr) Combinaison pharmaceutique et son utilisation
EP4014999A4 (fr) Produit de combinaison contenant un composé de limonine et un médicament à base de sulfonylurée
EP4048276A4 (fr) Formulations pharmaceutiques solides comprenant du ticagrelor
EP3962528A4 (fr) Combinaisons thérapeutiques comprenant des immunoconjugués anti-cd123
EP4058025A4 (fr) Compositions pharmaceutiques comprenant du ticagrelor
EP4005556A4 (fr) Composition pharmaceutique comprenant de l'udénafil
EP3694519A4 (fr) Combinaison pharmaceutique comprenant de la dapoxétine et de la phosphodiestérase de type 5
EP3746080A4 (fr) Formulations pharmaceutiques
EP3664800A4 (fr) Formulations thérapeutiques et leurs utilisations

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220315

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230708

A4 Supplementary search report drawn up and despatched

Effective date: 20230727

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 3/10 20060101ALI20230721BHEP

Ipc: A61K 9/20 20060101ALI20230721BHEP

Ipc: A61K 31/351 20060101ALI20230721BHEP

Ipc: A61K 31/155 20060101AFI20230721BHEP